Ibrutinib | Covalent Inhibitor of BTK
RATINGS:
Cellular Use: (0 reviews)

In Model Organisms: (0 reviews)
Control Compounds

Probe Summary

Targets Biochemical/Biophysical Potency Cellular Potency
BTK
  • IC50:0.5 nM
  • IC50:11 nM
  • IC50:29 nM
  • IC50:13 nM
Covalent Inhibitor
10 nM

Selectivity

In Vitro Selectivity Assessment
BLK

Gene ID: P51451

Organism: Homo sapiens

Family: Tyr protein kinase family

Potency: IC50 - 0.5 nM

In Vitro Selectivity Assessment
BMX

Gene ID: P51813

Organism: Homo sapiens

Family: Tyr protein kinase family

Potency: IC50 - 0.8 nM

In Cell Selectivity Assessment
Selectivity Assessment Description:
In primary cultures of T cells (which do not express Btk), up-regulation of CD69 induced by T cell r ...

Potency
Cellular
In Vitro

BTK

Mode of Action: Covalent Inhibitor

Structure-Activity-Relationship data available? Yes

DOI Reference: 10.1073/pnas.1004594107

In Vivo Validations

Mouse
Dose: 3.31 mg/Kg
Route of delivery: Oral
Plasma half life: 1.7 h
Systemic clearance: 79.8 L/h/Kg
Cmax: 0.101 uM
Tmax: 0.83 h
Area Under the Curve:: 0.09 uM*h

DOI Reference: 10.1073/pnas.1004594107

Dose: 14.2 mg/Kg
Route of delivery: Oral
Plasma half life: 3.1 h
Systemic clearance: 24.8 L/h/Kg
Cmax: 1.07 uM
Tmax: 0.33 h
Area Under the Curve:: 1.29 uM*h

DOI Reference: 10.1073/pnas.1004594107

Chemical Information

Molecular Formula C25H24N6O2
SMILEs C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1
InChI InChI=1S/C25H24N6O2/c1-2-21(32)30-14-6-7-18(15-30)31-25-22(24(26)27-16-28-25)23(29-31)17-10-12-20(13-11-17)33-19-8-4-3-5-9-19/h2-5,8-13,16,18H,1,6-7,14-15H2,(H2,26,27,28)/t18-/m1/s1
Molecular weight 440.20 Da
AlogP 0.0
HBond acceptors 8
HBond donors 2
Atoms 57

Vendors

Note: This is not an exhaustive list and does not indicate endorsement by the portal.

Expert Reviews


No SERP comments found for Ibrutinib

Probe Ibrutinib is in the process of SERP review.

Please continue to check back for new reviews and commentary.